Pages that link to "Q45256157"

The following pages link to Cross-linking of 4-1BB activates TCR-signaling pathways in CD8 T lymphocytes (Q45256157):

Displaying 24 items.

• 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity (Q27012963) (← links)
• Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells (Q34582700) (← links)
• The significance of OX40 and OX40L to T-cell biology and immune disease. (Q34979946) (← links)
• Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses (Q35082617) (← links)
• 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines (Q35781892) (← links)
• Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40 (Q35990308) (← links)
• Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens (Q36382421) (← links)
• Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism (Q36597479) (← links)
• Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules (Q38113962) (← links)
• The pharmacology of second-generation chimeric antigen receptors. (Q38541019) (← links)
• The future of immune checkpoint cancer therapy after PD-1 and CTLA-4. (Q38666253) (← links)
• Antigen-conjugated human IgE induces antigen-specific T cell tolerance in a humanized mouse model (Q39017240) (← links)
• Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus (Q39062801) (← links)
• Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L. (Q39938322) (← links)
• T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection (Q40047938) (← links)
• Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles (Q42234959) (← links)
• Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms. (Q43249169) (← links)
• Overview of Basic Immunology for Clinical Investigators. (Q52699143) (← links)
• CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs (Q59800859) (← links)
• CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia (Q59809962) (← links)
• Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling (Q64230450) (← links)
• CD134 expression on CD4 T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus (Q80031682) (← links)
• Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation (Q87906239) (← links)
• Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy (Q92689796) (← links)